Kerala received 60% more vaccine doses than proposed, says Centre

The Centre said, "It supplied adequate doses of COVID vaccines to Kerala under the National COVID-19 Vaccination programme."

Vaccine, Coronavirus vaccine, healthcare workers, health workers
ANI General News
2 min read Last Updated : Aug 11 2021 | 8:12 PM IST

The Central Government informed the Kerala High Court on Wednesday that the Centre has provided the state with 60 per cent more vaccine doses than the proposed allocation.

The statement was filed after the High Court sought a reply from the Union Government in a plea, filed by petitioners KP Aravindan and Dr Praveen G Pai, challenging the Liberalized Pricing and Accelerated National Covid-19 Vaccination Strategy.

The Centre said, "It supplied adequate doses of COVID vaccines to Kerala under the National COVID-19 Vaccination programme. Vaccines were supplied to States and Union Territories on a proportional basis of the eligible population, the progress of vaccination, and vaccine wastage."

Assistant Solicitor General P Vijayakumar, appearing for the Union Government, said in the submission, "As per the vaccine allocation for July 2021, the State was entitled to the allocation of 39,02,580 vaccines doses. However, it was supplied with 61,36,720 doses last month according to the report. This is 60% more than the proposed allocation for the State."

The Assistant Solicitor General said, "The Centre has provided enhanced supplies to the state in terms of vaccine distribution, citing that Kerala has vaccinated 55 per cent of its eligible population with the 1st dose compared with the national average of 42 per cent. The State has vaccinated 22 per cent of its population against 12 pc of the national average. So, Kerala has been supplied adequate doses of the vaccines under the National COVID-19 Vaccination Programme. The State would continue to be supplied adequate doses as per the availability of vaccines."

Petitioner Aravindan is a member of the COVID-19 expert panel constituted by the State and Pai is a public health specialist.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :KeralaCentreCoronavirus Vaccine

First Published: Aug 11 2021 | 8:07 PM IST

Next Story